Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Fatoumata Koita

Biographic Data

ID9801330
NAMEFatoumata Koita
GIVEN NAMESFatoumata
FAMILY NAMEKoita
SIGNATUREKOITA F
AFFILIATIONSUniversité des Sciences, des Techniques et des Technologies de Bamako
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context

    Open Access•Halimatou Diawara, Jane Grant et al.•ARTICLE•BMJ Global Health•2025

    BACKGROUND: The R21/Matrix-M malaria vaccine has been shown to provide high protective efficacy against malaria in a phase III trial, and has been recommended for use by WHO. The vaccine will soon be deployed at scale in sub-Saharan Africa. This study aimed to understand the caregiver and community acceptability of the R21/Matrix-M vaccine alongside existing malaria prevention interventions, according to the communities of participants in the sea…

  • Delivery strategies for malaria vaccination in areas with seasonal malaria transmission

    Open Access•Jane Grant, Halimatou Diawara et al.•ARTICLE•BMJ Global Health•2023

    Background Seasonal vaccination with the RTS,S/AS01 E malaria vaccine given alongside seasonal malaria chemoprevention (SMC) substantially reduces malaria in young children. The WHO has recommended the use of RTS,S/AS01 E , including seasonal vaccination, in areas with seasonal malaria transmission. This study aimed to identify potential strategies to deliver RTS,S/AS01 E , and assess the considerations and recommendations for delivery of seasona…

  • Cost of introducing and delivering malaria vaccine (RTS,S/AS01 E ) in areas of seasonal malaria transmission, Mali and Burkina Faso

    Open Access•Halimatou Diawara, Fadima Yaya Bocoum et al.•ARTICLE•BMJ Global Health•2023

    BACKGROUND: malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. METHODS: Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Imm…

No prominent works on this page.

  • Delivery strategies for malaria vaccination in areas with seasonal malaria transmission

    Open Access•Jane Grant, Halimatou Diawara et al.•ARTICLE•BMJ Global Health•2023

    Background Seasonal vaccination with the RTS,S/AS01 E malaria vaccine given alongside seasonal malaria chemoprevention (SMC) substantially reduces malaria in young children. The WHO has recommended the use of RTS,S/AS01 E , including seasonal vaccination, in areas with seasonal malaria transmission. This study aimed to identify potential strategies to deliver RTS,S/AS01 E , and assess the considerations and recommendations for delivery of seasona…

  • Cost of introducing and delivering malaria vaccine (RTS,S/AS01 E ) in areas of seasonal malaria transmission, Mali and Burkina Faso

    Open Access•Halimatou Diawara, Fadima Yaya Bocoum et al.•ARTICLE•BMJ Global Health•2023

    BACKGROUND: malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. METHODS: Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Imm…

  • Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context

    Open Access•Halimatou Diawara, Jane Grant et al.•ARTICLE•BMJ Global Health•2025

    BACKGROUND: The R21/Matrix-M malaria vaccine has been shown to provide high protective efficacy against malaria in a phase III trial, and has been recommended for use by WHO. The vaccine will soon be deployed at scale in sub-Saharan Africa. This study aimed to understand the caregiver and community acceptability of the R21/Matrix-M vaccine alongside existing malaria prevention interventions, according to the communities of participants in the sea…

Environmental health (3 works) · Immunology (3 works) · Malaria (3 works) · Malaria Research and Control (3 works) · Malaria vaccine (3 works) · Medicine (3 works) · Plasmodium falciparum (3 works) · Vaccination (3 works) · Global Maternal and Child Health (2 works) · Nursing (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae